Scientists have found a new drug that can be used to treat fatty liver

Nonalcoholic steatohepatitis (NASH) affects 10% to 15% of type 2 diabetic obese patients worldwide But now scientists believe they have found a pharmacological way to inhibit Nash, which can prevent the fatal diseases caused by Nash, such as cirrhosis and liver cancer Dr Tadashi Honda, research professor, Department of chemistry, Shixi University, director of ICB & DD anti inflammatory research laboratory, and colleagues from Dundee University and St Andrews University are testing a drug called tbe-31 (http:// The researchers found that tbe-31 activates a protein called Nrf2 in mice that neutralizes a group of oxidants in the damaging liver called reactive oxygen species (ROS) It is found that tbe-31 can block the accumulation of ROS in NASH, thus preventing liver injury and treating the disease The research is published in a new edition of cellular and Molecular Gastroenterology and hepatology However, there is no known drug for NASH NASH individuals can only reduce the incidence rate and complications of disease by changing their lifestyle.